11th October
Current Perspectives in Haematological Malignancies

Manchester Conference Centre, Sackville Street, Manchester, M1 3BB

Chairs: Dr Mike Dennis (Manchester) and Professor Tim Illidge (Manchester)

Myeloma – upfront and RRMM
CLL – heading for a cure?
MPN update – focus on MF
High risk and resistant CML: new diagnostic tools and treatment approaches
Workshop: AML

ECHELON 1 : Brentuximab should be used first line in advanced Hodgkin lymphoma
GALLIUM : Obinutuzumab, not rituximab, should be used first line for patients with symptomatic follicular lymphoma

Confirmed Speakers:

  • Professor Tim Illidge (Christie Hospital, Manchester)
  • Professor Graham Jackson (NCCC, Newcastle)
  • Dr Andrew McMillan (Nottingham City Hospital)
  • Dr Wendy Osborne (Freeman Hospital, Newcastle)
  • Dr Steve Knapper (University Hospital, Wales)
  • Dr Mike Dennis (Christie Hospital, Manchester)
  • Professor Claire Harrison (Guy’s and St Thomas’ Hospital, London)
  • Dr Hugues de Lavallade (King’s College Hospital, London)

Registration Fees:

(inclusive of VAT @ 20%)


Trainees / Nurses*

Standard Fee (until 25th September)



Late Fee (from 26th September)




* 20 free places available for Trainees & Nurses (allocated on a first-come, first-served basis – please email alex@hartleytaylor.co.uk to check availability)


Registration questions: alex@hartleytaylor.co.uk
Sponsorship opportunities: julie@hartleytaylor.co.uk

Hartley Taylor Medical Communications Ltd
2, St George’s Court | St George’s Park
Kirkham | PR4 2EF